AIチャット
Loading data for PMHS — first visit, this takes a few seconds.

Polomar Health Services, Inc.

PMHS · OTC Markets OTCQB · USD

0.20 +0.00 (0.00%)

終値時点: Sep 14, 2026, 8:00 PM

Polomar Health Services, Inc.(PMHS)の株価・分析・データ

本質的価値

本源的価値を読み込み中…

アナリスト予想

株価予想 →

アナリスト予測は利用できません

12か月目標株価 · アナリストn/a人

アナリストのコンセンサス: n/a

間隔:1D
ローソク足とシグナルを読み込み中…

業績

財務情報を見る →

読み込み中...

最新決算

実績予想との差前年比
売上高n/an/a
EPS(TTM)n/an/a

次回決算

決算の詳細を見る →

事業指標

買気配
0.17
純利益(TTM)
-9.55M
n/a
-0.35
n/a
n/a
PBR(TTM)
-5.41
PSR(TTM)
1.79
決算発表日
n/a
売気配
0.3
出来高
5,000
平均出来高(20日)
3,192
始値
0.21
前日終値
0.20
当日レンジ
0.21 - 0.21
52週レンジ
0.07 - 0.80
配当
n/a
権利落ち日
n/a
ニュース記事はまだありません

Polomar Health Services, Inc.について

企業情報を見る →
Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California. Pharmaceutical Retailers · Healthcare

Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

セクター Healthcare
IPO日 Feb 9, 2009
従業員数 6
上場取引所 OTC Markets OTCQB
ティッカー PMHS
ウェブサイト https://polomarsp.com